Paradigm Outcomes Welcomes John Watts Jr. as CEO, Closes

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
161
Paradigm Outcomes Welcomes John Watts Jr. as CEO, Closes ForeSight Medical Acquisition, and Retains Jim Hudak as Executive Chairman

WALNUT CREEK, Calif., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Paradigm Outcomes today announced the appointment of John Watts Jr. to the Chief Executive Officer position. Watts will lead the strategic expansion of the nation’s leading provider of catastrophic and complex care management solutions. He will retain his position on the Board of Directors. Jim Hudak, who has served as Paradigm’s CEO since 2011, will become Executive Chairman, thereby implementing a designed succession plan.

“This is the perfect time for John to become Paradigm’s next Chief Executive Officer,” said Paradigm Chairman and CEO Jim Hudak. “With our continued growth and the strategic addition of ForeSight Medical, Paradigm is becoming a more diverse and complex organization. We are fortunate to strengthen our company and add a senior leader to the Paradigm team.”

Watts brings a 35-year career in healthcare, leading large payor organizations and advising several private equity backed healthcare companies. Previously, Watts spent 12 years at Anthem, then the nation's largest health insurer. While at Anthem, he held numerous management positions, including President and CEO of Blue Cross Blue Shield of Georgia, President and CEO of Anthem National Accounts, and President and CEO of Anthem’s Commercial and Consumer Business, where he directed a $50 billion division that encompassed 14 Blue Cross Blue Shield plans.

Since leaving Anthem, Watts has served as Executive Chairman of several venture or private equity backed companies including Healthplan Holdings, International Medical Group, Implantable Provider Group and MdDatacor. He also served as a Managing Director of CCI, a specialty consulting firm that works with McKinsey & Company to manage peer to peer forums for CEOs and their direct reports in healthcare and technology. Watts has also served on the boards of CareCentrix and Metcare, Blue Cross and Blue Shield of Minnesota and CDx Holdings.

“I joined the Paradigm board because I believe in the company’s mission of improving outcomes for individuals with complex medical needs, and I support the unique business model of taking clinical and financial risk for the cases they manage,” said Watts. “At a time when the healthcare industry is striving to find new ways to improve outcomes and deliver value on high-cost cases, Paradigm’s focus and opportunity is more relevant than ever.”

Paradigm announced a definitive agreement to purchase ForeSight Medical last month. That purchase closed on October 12. ForeSight’s suite of surgical management solutions combined with Paradigm’s expertise in complex and catastrophic injuries will form the most comprehensive resource available for high-cost, high-acuity and complex care management for the workers’ compensation marketplace and beyond. Last year, Paradigm acquired two case management companies, The ALARIS Group and Encore Unlimited.

During his tenure as Paradigm’s CEO, Hudak oversaw the three strategic acquisitions, advanced the company's leadership position in catastrophic care management, diversified and expanded Paradigm’s customer base and grew revenues and EBITDA four-fold. Hudak has gained a reputation in the industry for his deep commitment to customer success and to helping catastrophically injured workers restore function and return to work.

Watts will assume the Paradigm Chief Executive Officer role effective October 16.

About Paradigm Outcomes

Paradigm Outcomes is the market leader in managing catastrophic and complex cases for the workers’ compensation industry.  Paradigm’s core business provides clinically-driven comprehensive care management programs for people with acquired brain injuries, spinal cord injuries, multiple traumas, amputations, burns and chronic pain, achieving 5x better medical outcomes and lowering total costs by 40% compared to industry benchmarks. Together with its wholly owned subsidiaries The ALARIS Group, Encore Unlimited and ForeSight Medical, Paradigm works to improve health outcomes and lower medical spend for high-cost, complex cases. For more information, visit www.paradigmcorp.com .

Media Contact Liz Agnello elizabeth.agnello@paradigmcorp.com 925.677.4936

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CACI Hits $50K Milestone in Service Dog Program

Updated Category News Views 13

Ice Blocking for a Noble Cause Last I checked, mixing the adrenaline of ice hockey with the grit of veteran support isn't your typical skate on thin ice. But CACI International Inc (NYSE:CACI), with their Good Dogs for Great Americans program, is doing just that. They're taking every blocked shot by the Washington Capitals and turning it into a stepping stone for veterans...

Continue Reading
Jacquie Lawson's Advent Calendar Delights Fans for 17th Year

Updated Category News Views 63

A Festive Tradition with a Twist The Jacquie Lawson Advent calendar is back for its 17th season, and it's no ho-hum affair. This time, the scene is set against the breathtaking backdrop of England's Lake District. If you've been yearning for a bit of that classic literary and natural charm, this is your ticket—minus the airfare. The calendar isn't just a countdown; it's...

Continue Reading
LifeStance Expands Access to Esketamine, TMS

Updated Category News Views 87

LifeStance Health's Treatment Innovations Today, the spotlight is on LifeStance Health, as they're making waves with their treatment approaches for those battling stubborn, treatment-resistant depression. This isn't your run-of-the-mill attempt at tackling the beast—that familiar indifference masked as hope. No, this time around, they’re swinging with Esketamine and...

Continue Reading
OCI Cleared to Merge with Orascom, Sets Delisting Date

Updated Category News Views 117

OCI N.V. has hit a milestone. The shareholders have given the green light to merge with Orascom Construction PLC. This move is fleshed out with an updated roadmap that sharp-eyed investors need to watch closely. The company's shares will no longer be trading on Euronext Amsterdam by late November 2026, contingent on regulatory nods and other variables swirling in the...

Continue Reading
Sentral Expands: Fort Lauderdale & San Diego Additions

Updated Category News Views 112

Sentral's Strategic Leap into New Markets Ever heard of a company spreading its wings like wildfire? That’s Sentral for you, crashing into Fort Lauderdale and pushing deeper roots in San Diego. We’re not talking minor plays here—these two fresh additions make Sentral a resident-giant stretched across 22 markets. Seems like they’re on a mission to ink their mark...

Continue Reading
Lecanemab's New Data: What Investors Should Monitor

Updated Category News Views 35

Lecanemab: A Bold Step in Alzheimer's Treatment? Investors eyeing the biotech sector should pay close attention to the upcoming CTAD conference in 2026, where BioArctic AB's partner, Eisai, is set to present fresh data on lecanemab (Leqembi®). This isn't just another pharma front-page story—this is about potential breakthroughs in Alzheimer's treatment that's caught...

Continue Reading
WhiteFiber's Q3 2026 Call: Key Insights Await Investors

Updated Category News Views 51

Eyes on WhiteFiber's Upcoming Earnings Call You know the drill—results call season can make or break some days for us investors. WhiteFiber, Inc. (NASDAQ: WYFI) is gearing up for their third-quarter earnings call on November 10, 2026, at 9:00 a.m. Eastern Time. As a player in the AI infrastructure game, expectations ride high. With their networks and data centers...

Continue Reading
Kansas City Life's Q3: Earnings Dip, but Growth Ahead

Updated Category News Views 0

Striking a Balance: Kansas City Life's Q3 They say numbers don’t lie, and Kansas City Life Insurance just shared their latest. This quarter, things weren't all smooth sailing, but there's a silver lining. For Q3 2026, net income clocked in at $1.7 million, or $0.18 per share, down from last year’s $2.8 million, or $0.29 per share. Sure, it wasn't all sunshine and...

Continue Reading
Shareholder Stakes at Risk in Major Mergers

Updated Category News Views 15

Deals in the Spotlight: What's at Stake? Ever wonder if you're getting the short end of the stick while company insiders walk away with the spoils? That's the song and dance investors face with the likes of ADT Inc., Instacart, and MidCap Financial Investment Corporation lately. If you're wearing the shareholder hat, you might want to tune into the noise around these...

Continue Reading
Hehe Culture's Timeless Wisdom Explored at Forum

Updated Category News Views 39

Hehe Forum: Bridging the Past and Present Sometimes, the past isn't just anchor weight, it's a compass guiding us through the murky waters of today. The Hehe Culture Forum's latest gathering in Tiantai County, Zhejiang Province, aimed to unravel just how much ancient wisdom can still steer the course in this fast-changing world. Delegates from 23 nations joined forces,...

Continue Reading

Top 5 Most Recently Viewed Articles

RedThread Literacy: A Fresh Approach to K-8 Learning

Updated Category News Views 43

RedThread Literacy Commands Attention Amidst the relentless churn of education systems, fresh approaches are always vying for a spotlight. RedThread Literacy, a brainchild of Lavinia Group, certainly seems to have cut through the noise. These folks at K12 Coalition have integrated what they claim to be the Science of Reading—no small feat in a K-8 program. And hey, The...

Continue Reading
Aave Enhances Revenue with Chainlink SVR Integration

Updated Category News Views 145

Aave Enhances Revenue with Chainlink SVR Integration In a significant step forward for decentralized finance (DeFi), the Aave community has officially integrated Chainlink Smart Value Recapture (SVR) on the Ethereum Mainnet. This integration aims to recapture liquidation maximal extractable value (MEV), which has historically escaped to other blockchain participants....

Continue Reading
KeyBanc Adjusts Global Payments Price Target but Remains Positive

Updated Category News Views 56

KeyBanc just threw a curveball at Global Payments Inc. (NYSE: GPN), slicing its price target down from $145 to $135. Now, you might think that’s a red flag, but don’t break out the panic buttons just yet—the firm has kept its Overweight rating on the stock. They still see potential in this payment tech giant despite shifting market dynamics. The Investor Day Game...

Continue Reading
Bitcoin Faces Pressures Amid Election Uncertainties and Rates

Updated Category News Views 75

Market Outlook for Bitcoin Amid Political Tensions Bitcoin, the leading cryptocurrency, recently saw a decline as market participants showed reduced appetite for risk. Factors contributing to this downturn include ongoing uncertainties surrounding the U.S. presidential election and anticipations of interest rate adjustments by the Federal Reserve. Bitcoin's Current Market...

Continue Reading
Alphabet's Revenue Growth in Cloud and YouTube Highlights Future Potential

Updated Category News Views 264

Alphabet's Strong Performance and Future Prospects Recent analysis from Goldman Sachs has emphasized the continued success of Alphabet Inc. (NASDAQ: GOOGL) as it navigates through the rapidly evolving tech landscape. With a maintained Buy rating, analysts point to crucial developments in the company’s core sectors such as Search, YouTube, and Cloud. Key Business...

Continue Reading